Celldex Therapeutics Inc (CLDX)

01:12 AM

Celldex earnings on deck as barzolvolimab Phase 3 nears readout - Investing.com

01:12 AM

08:11 AM

[ARS] Celldex Therapeutics, Inc. SEC Filing - Stock Titan

08:11 AM

08:00 AM

Celldex (NASDAQ: CLDX) sets 2026 virtual meeting, seeks approval for equity plan - Stock Titan

08:00 AM

07:41 AM

Celldex prices $300M stock at $29 per share to fuel Barzolvolimab launch - MSN

07:41 AM

Apr 28, 2026

Celldex Therapeutics announces public offering of common stock - MSN

Apr 28, 2026

Apr 25, 2026

Is Celldex Therapeutics (CLDX) Still Attractive After A 70% One Year Share Price Jump - Yahoo Finance

Apr 25, 2026

Apr 23, 2026

Is Celldex (CLDX) stock a strategic buy | Q4 2025: EPS Misses ViewsCommunity Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 23, 2026

Celldex (CLDX) Operational Review | Q4 2025: Earnings UnderperformPrice Target - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 22, 2026

Assessing Celldex Therapeutics (CLDX) Valuation After Strong Recent Share Price Gains - simplywall.st

Apr 22, 2026

Apr 22, 2026

Why Celldex Stock Is Suddenly Sliding Again - TipRanks

Apr 22, 2026

Apr 21, 2026

Celldex Therapeutics Inc (CLDX) - MSN

Apr 21, 2026

Apr 21, 2026

Barclays upgrades Celldex Therapeutics (CLDX) - MSN

Apr 21, 2026

Apr 21, 2026

Celldex (CLDX) Stock VWAP Analysis (-0.49%) 2026-04-20AI Powered Stock Picks - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 21, 2026

Apr 20, 2026

Celldex Therapeutics (NASDAQ:CLDX) Shares Gap Up Following Analyst Upgrade - MarketBeat

Apr 20, 2026

Apr 20, 2026

Barclays Upgrades Celldex Therapeutics to Overweight From Underweight, Adjusts Price Target to $45 From $24 - marketscreener.com

Apr 20, 2026

Apr 20, 2026

Barclays upgrades Celldex stock rating on trial enrollment progress By Investing.com - Investing.com Australia

Apr 20, 2026

Apr 20, 2026

Barclays upgrades Celldex stock rating on trial enrollment progress - Investing.com UK

Apr 20, 2026

Apr 18, 2026

Celldex (CLDX) Stock: Performance Drivers (Modest Uptick) 2026-04-18Real Trader Network - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026

Apr 18, 2026

Celldex Therapeutics stock hits 52-week high at 34.55 USD By Investing.com - Investing.com India

Apr 18, 2026

Apr 17, 2026

Celldex Therapeutics (NASDAQ:CLDX) Sets New 12-Month HighHere's What Happened - MarketBeat

Apr 17, 2026

Apr 17, 2026

Celldex Therapeutics stock hits 52-week high at 34.55 USD - Investing.com

Apr 17, 2026

Apr 17, 2026

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 17, 2026

Apr 15, 2026

Tudor Investment Corp ET AL Makes New $818,000 Investment in Celldex Therapeutics, Inc. $CLDX - MarketBeat

Apr 15, 2026

Apr 15, 2026

Celldex Therapeutics Spotlights Barzolvolimab as Phase III CSU Data Looms After Fast Enrollment - MarketBeat

Apr 15, 2026

Apr 14, 2026

CLDX: Barzolvolimab shows strong, durable efficacy in urticaria with pivotal phase III data due Q4 - TradingView — Track All Markets

Apr 14, 2026

Apr 13, 2026

Celldex to Present at Upcoming Investor Conference - The Manila Times

Apr 13, 2026

Apr 12, 2026

Celldex Therapeutics Raises $345 Million in Public Offering of Common Stock - Global Legal Chronicle

Apr 12, 2026

Apr 09, 2026

A Look At Celldex Therapeutics (CLDX) Valuation After Equity Raise And New Barzolvolimab Data - Sahm

Apr 09, 2026

Apr 08, 2026

Precision Trading with Celldex Therapeutics Inc. (CLDX) Risk Zones - Stock Traders Daily

Apr 08, 2026

Apr 08, 2026

What do ownership trends show for Celldex (CLDX) Stock | Price at $31.79, Up 1.39%Theta Decay - Cổng thông tin điện tử Tỉnh Sơn La

Apr 08, 2026

Apr 07, 2026

RSI Check: Why is Vistagen Therapeutics Inc stock going downBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Celldex Therapeutics Closes $345M Public Stock Offering - National Today

Apr 07, 2026